MetaCap

XTL Biopharmaceuticals (XTLB) News

NASDAQ: XTLBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.37-0.085 (-5.84%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

XTLB news summary

We found 2 recent headlines mentioning XTL Biopharmaceuticals (XTLB): 2 in the past week and 2 in the past 30 days, most often from Nasdaq. XTLB is making an outsized move today, down 5.84% at $1.37, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "XTL Biopharmaceuticals Ltd. to Hold Extraordinary General Meeting to Approve Name Change to Psyga Ltd., CEO Appointment, and US$1,000,000 Private Placement", was published by Nasdaq on Nov 20, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest XTL Biopharmaceuticals headlines

Compare XTLB